財通福鑫定開混合：本基金將於2026年7月14日開盤起至當日10:30停牌。

Intel (INTC.O) will invest €5 billion ($5.7 billion) to expand its Leixlip campus near Dublin, increasing capacity for data‑center processors, including flagship Xeon server CPUs, and boosting R&D. The company said the expansion is part of plans to raise data‑center processor output and, Executive VP Naga Chandrasekaran said, to improve delivery for foundry customers as it seeks to bolster its foundry business. Intel framed the investment as an effort to regain manufacturing leadership amid the AI boom and to strengthen competition with TSMC.

China's State Council issued the National Health 15th Five-Year Plan, committing full-chain support for innovative drugs and medical devices. It directs regulators to optimize review and approval of innovative and clinically urgent medicines and to establish a comprehensive clinical evaluation system to support clinical use. The plan calls for accelerated R&D and application of cell and gene therapies, next‑generation antibodies, new vaccines, nucleic‑acid drugs and radiopharmaceuticals, and for strengthened emergency vaccine and drug R&D, production and deployment. It seeks to expand pediatric drug options, deepen medtech–clinical collaboration and boost R&D of core technologies, components and finished high‑end devices. The plan also promotes AI across the pharma and medtech value chain and instructs improvement of health‑insurance support mechanisms, including refinement of the innovative‑drug reimbursement/catalogue.